Skip to main content
Equibles

Katrin Rupalla

Board Member

ZyVersa Therapeutics, Inc. (ZVSA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Katrin Rupalla

Katrin Rupalla is recorded as Board Member at ZyVersa Therapeutics, Inc. (ZVSA). ZyVersa Therapeutics, Inc. reported in an 8-K filed May 19, 2023 that Katrin Rupalla resigned as Board of Directors, effective May 18, 2023. ZyVersa Therapeutics, Inc. reported in an 8-K filed January 6, 2023 that Katrin Rupalla was appointed member of the board, effective January 5, 2023.

“On May 17, 2023, Katrin Rupalla, Ph.D., notified the Board of Directors (the "Board") of ZyVersa Therapeutics, Inc. (the "Company") that she was resigning from the Board effective May 18, 2023.”
ZyVersa Therapeutics, Inc. Form 8-K, filed May 19, 2023 · Read the filing
“On January 5, 2023, the Board of Directors (the “Board”) of ZyVersa Therapeutics, Inc., a Delaware corporation (the “Company” or “ZyVersa”), appointed James Sapirstein, Gregory Freitag, and Katrin Rupalla to serve as members of the board to fill the three vacancies created as a result of the business combination between ZyVersa Therapeutics, Inc., a Florida corporation (“Old ZyVersa”) with Larkspur Health Acquisition Corp. (“Larkspur”), which was consummated on December 12, 2022 (the “Business Combination”).”
ZyVersa Therapeutics, Inc. Form 8-K, filed January 6, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at ZyVersa Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.